Bioequivalence of Fluzoparib(SHR3162) Study on Healthy Chinese Adult Subjects

Clinical trial NCT04521192 · COMPLETED

Trial details

NCT number: NCT04521192
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Adult Subjects

Start date: 2019-05-06
Primary completion: 2019-07-26
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.